If your asthma still flares despite regular inhalers, oral steroid courses, or repeated emergency visits, you may have severe asthma β and there is now a targeted treatment beyond inhalers. Dr. Rahul Katyal, MD Pulmonary Medicine, assesses severe asthma and biologic eligibility at Gini Hospital, Mohali.
π Sector 69, SAS Nagar (Mohali), Punjab Β· Serving Chandigarh Tri-City
Not all asthma is the same. A small but important group of patients have asthma that stays out of control no matter how many inhalers they use β this is what specialists call severe asthma.
Most people with asthma achieve good control with a preventer (inhaled steroid) inhaler and a reliever inhaler. Severe asthma is different: it is asthma that remains uncontrolled despite high-dose inhaled corticosteroids combined with a second controller medicine, or that only stays controlled with repeated courses of oral steroids. Doctors distinguish this from "difficult-to-treat" asthma, where the real problem is poor inhaler technique, missed doses, ongoing triggers, or an untreated related condition.
The distinction matters because true severe asthma may respond to newer targeted treatments, whereas difficult-to-treat asthma usually improves once the basics are corrected. Sorting out which group you fall into is the first job of the specialist assessment.
Inhaled steroids calm airway inflammation in general. But some severe asthma is driven by specific immune pathways that these inhalers simply do not switch off.
In many people with severe asthma, the airway inflammation is what doctors call "type 2" inflammation β driven by particular immune signals such as IgE antibodies and the interleukins IL-5 and IL-4/IL-13. Inhaled corticosteroids reduce inflammation broadly, but they do not specifically block these signalling pathways. So even at high doses, the underlying driver of the attacks keeps working and symptoms persist.
Escalating to higher and higher inhaler doses, or relying on repeated oral steroid courses, then exposes patients to side effects β weight gain, raised blood sugar, bone thinning, and cataracts β without solving the root problem. This is exactly the situation where a specialist looks beyond inhalers.
The breakthrough is that we can now identify these pathways with simple blood tests and then block them directly. That is what biologic therapy does.
Biologics are targeted medicines (monoclonal antibodies) given as injections, usually once every few weeks. Instead of blanketing the whole immune system, each one blocks one specific inflammatory pathway that drives severe asthma. Because they act on the root driver rather than just the symptoms, they can reduce or even eliminate attacks and cut down or stop the need for oral steroids.
Below are the drug classes used in severe asthma, described by the pathway they target. The right class depends on your individual asthma phenotype, which the specialist assessment identifies.
[CONFIRM: which specific biologic drugs does Gini currently prescribe? β omalizumab, mepolizumab, dupilumab?] Until confirmed, this page describes biologic drug classes only and does not name specific brands as available at Gini.
Biologics are not for everyone with asthma β they are reserved for genuine severe asthma with the right inflammatory signature.
Your asthma stays uncontrolled even on correctly used high-dose inhaled steroids plus a long-acting bronchodilator.
You have had repeated flare-ups, emergency visits, or several courses of oral steroids over the past year.
Blood tests (such as eosinophil count and IgE) point to type 2 inflammation that a biologic can target.
Inhaler technique, adherence, triggers, and related conditions have been reviewed and addressed first.
Final eligibility is always a clinical decision. Dr. Rahul Katyal confirms the asthma diagnosis, matches your phenotype to the right biologic class, and reviews suitability before any biologic is recommended.
A structured severe asthma work-up confirms the diagnosis and identifies whether targeted therapy will help.
A detailed history and examination, plus lung function testing (spirometry / PFT), to be sure the problem really is asthma and to grade its severity.
Reviewing how you use your inhaler, whether doses are being missed, and what triggers or related conditions (allergies, reflux, sinus disease) may be driving symptoms.
Blood tests including eosinophil count and IgE (and, where indicated, further airway inflammation markers) to reveal which inflammatory pathway is active.
If a biologic is appropriate, Dr. Katyal matches your phenotype to the correct drug class and explains the plan, monitoring, and what response to expect. If not, the plan is optimised in other ways.
Dr. Rahul Katyal is Gini Hospital's lead pulmonologist and Director of Critical Care. He manages the full spectrum of respiratory conditions, with a particular focus on severe asthma that has not responded to standard inhaler therapy. As ICU Director, he is also the right specialist to see if your asthma has previously required emergency or intensive care β because the same team that assesses you for biologics is the team that manages acute attacks.
OPD: MonβSat Β· 10:00 AM β 6:00 PM Β· Gini Advanced Care Hospital, Sector 69, Mohali
Severe Asthma Β· Biologic Eligibility Β· Lung Function Testing Β· ICU On Site